The airway management devices market size is projected to reach US$ 3.82 billion by 2031 from US$ 2.21 billion in 2023. The market is expected to register a CAGR of 7.1% during 2023–2031. The rise in the prevalence of respiratory disorders is followed by new product launches and approval, research and development activities, and collaboration among the market players are likely to remain key trends in the market.
Chronic respiratory diseases is the most prevalent noncommunicable diseases across the world due to the increase in the noxious environment and occupational and toxic behavioral inhalation. This scale of diseases includes chronic obstructive pulmonary disease (COPD), asthma, pulmonary sarcoidosis, interstitial lung disease, and pneumoconiosis (such as silicosis and asbestosis). According to the World Health Organization (WHO), COPD is responsible for the third leading cause of death globally. The Global Asthma Report 2019, states that ~300 million people have asthma worldwide, and the estimates indicate this number will surge by 100 million people by 2025. As per the WHO report, asthma affected 262 million people globally and caused 455,000 deaths in 2019. Moreover, in 2019, asthma resulted in 439,000 hospitalizations and an estimated 1.3 million visits every year in the US. The rising prevalence of respiratory disorders is driving the global demand for airway management devices. Thus, the factors mentioned above are driving the airway management devices market.
Increase in investments & funds for airway management devices, rising numbers of start-up companies, and technological advancements are key drivers for the increase of the market. However, the growth of the market is restricted by various factors, such as a lack of skilled professionals and long approval processes. Gene synthesis is an established market in some regions such as Japan, whereas, with some recent progress in countries such as India, China, Indonesia, and Taiwan, it is expected that a major chunk of the demand will be generated from the above-mentioned countries. Additionally, factors such as increasing emphasis on industry players in Japan and India and funds grants in the country like China are likely to propel the growth of the market.
The increasing frequency of various chronic disorders, such as COPD, asthma, cystic fibrosis, and emphysema, among a large population globally, has promoted product launches, new product developments and approvals on a global level. Additionally, the majority of market competitors focused on research and development activities to ensure the invention and development of efficient products. In July 2022, Verathon announced the release of the BFlex 2.8 Single-use Bronchoscope. BFlex single-use bronchoscopes are designed specifically for the critical needs of the ICU, OR, and ED. The BFlex 2.8 is Verathon’s first single-use pediatric bronchoscope and delivers the drivability and image quality needed for pediatric bronchoscopies, airway management, and lung isolation procedures. In addition, In May 2021, Olympus Corporation received FDA 510(k) clearance for its Airway Mobilescopes—MAF-TM2, MAF-GM2, and MAF-DM2—enabling providers to perform a variety of upper and lower airway management procedures. Thus, an increase in product development, approvals and launches is likely to drive the airway management devices market in the near future
Significant development in healthcare facilities and services globally has increased the demand for various products, including single-use devices. Nowadays, single-use devices are widely used on a global level owing to several benefits, such as increased patient safety, reduced healthcare-associated infections, and better management of respiratory infectious diseases. Single-use airway management devices are pre-sterilized and can be directly used, saving a lot of cleaning and sterilization time. These devices are widely used for handling patients suffering from highly infectious diseases, such as severe pneumonia and H1N1 influenza. Moreover, the COVID-19 pandemic has created a demand for single-use airway management devices to treat COVID-19 patients, which is further expected to reduce the spread of infections. Additionally, severe cases of COVID-19 require ventilator support and intubation, which has increased the use of single-use tracheal tubes.
Furthermore, the rising number of emergency cases, such as heart attack, stroke, breathing difficulties, and fatal road accidents, along with the increasing burden of the aging population prone to respiratory disorders, is expected to create growth opportunities. Additionally, the surge in the R&D investments and funds granted by government bodies to improve the emergency care infrastructure and services is further expected to create opportunities for market growth in the coming years.
Key segments that contributed to the derivation of the airway management devices market analysis are products and end users.
The geographic scope of the XYZ market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the market. In North America, the US is dominating the airway management market due to the rising incidence of respiratory disorders, which is believed to fuel the growth of this market in the future. Currently, chronic obstructive pulmonary disease (COPD) and asthma are major health burdens in the US. Asthma is a lung disorder with chronic inflammation due to airway narrowing and obstruction. Smoking is the major cause of COPD in the US. Increasing smoking in the US is driving the growth of the airway management devices market. According to the Centers for Disease Control and Prevention (CDC), 2020, about 5.0% of adults are diagnosed with emphysema, COPD, or chronic bronchitis in the United States. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.
The regional trends and factors influencing the Airway Management Devices Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Airway Management Devices Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 2.21 Billion |
| Market Size by 2031 | US$ 3.82 Billion |
| Global CAGR (2023 - 2031) | 7.1% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Airway Management Devices Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Airway Management Devices Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The airway management devices market is evaluated by gathering qualitative and quantitative data from primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the Airway Management Devices market are listed below:
The “Airway Management Devices Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
The airway management devices market size is projected to reach US$ 3.82 billion by 2031
Rise in orevalence of respiratory disorder, followed by new product launch drive the airway management devices market size
The Airway Management Devices market majorly consists of the players such Teleflex Incorporated; Smiths Medical; Medtronic; Intersurgical Ltd; Ambu A/S; Medline Industries, Inc.; Koninklijke Philips N.V.; Armstrong Medical; and Mercury Medical.
Based on geography, the airway management devices market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the largest contributor to the growth of the global ENT devices market. Asia Pacific is expected to register the highest CAGR in the airway management devices market during 2023–2031
The market is expected to register a CAGR of 7.1% during 2023–2031